Key take: GLP-1s represent a new frontier, signaling the dawn of real preventive and longevity medicine, but theres still a long road before we see longevity drugs for everyone
This treatment leaves behind a trail of people who are forced to face paralyzing pain, chronic fatigue and serious mental damage
Our goal in the current study was to develop a predictive model that could guide the use of GLP-1 M medications for the treatment of T2D in the real world
Test battery performance with controlled discharge and compare results to specifications
The progression of disease is slow and symptoms can take a few years to present
Yao S, Yuan Y, Zhang H, Meng X, Jin L, Yang J, et al